Company intelligence / Profile preview

Areterna

Gaithersburg, Maryland, United Statesareterna.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Areterna has developed multiple cost-effective animal vaccine candidates using its proprietary mRNA platform, including vaccines for rabies, FIPV, and PEDV. The company is not a direct developer of human therapeutics but provides GMP-grade raw materials and services that have supported over 30 clinical programs globally. Its core strengths are in mRNA design, manufacturing, LNP formulation, and analytical testing

Therapeutic areas: Infectious Diseases
Modalities: mRNA-based drugsOligonucleotide therapeuticsLipid nanoparticle delivery therapy (for mRNA/LNP manufacturing)
Industry: Veterinary

Partnerships

BIORON GmbH – global distribution agreement for molecular biological products/services across EuropeBiomay – strategic partnership to jointly serve CDMO customers with GMP manufacturing of RNA products and access to Areterna’s low-cost cap analogs/NTPs/modified NTPs

Beyond the preview

Go deeper on Areterna.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Areterna.

Explore the full profile